Novel Antibiotics Approved by the FDA (2022–2025)
Antimicrobial resistance (AMR) is a growing global health crisis, emphasizing the urgent need for new antibiotics. Despite high costs and long development timelines, several novel antibiotics were approved by the U.S. Food and Drug Administration (FDA) between 2022 and 2025. This review summarizes the antibiotic discov...